![Adial Pharmaceuticals, Inc. Website Screenshot](https://www.watchmycompetitor.com/UsersData/publicpages/id-79-date-2020-08-03.png)
http://www.adialpharma.com
Adial Pharmaceuticals, Inc. Company Intro
page-template-default,page,page-id-16087,page-child,parent-pageid-16092,bridge-core-2.0.9,ajax_fade,page_not_loaded,,qode-theme-ver-19.6,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,wpb-js-composer js-comp-ver-6.2.0,vc_responsive
Industry
Healthcare
Adial Pharmaceuticals, Inc. Headquaters
1180 Seminole Trail
Charlottesville,22901
United States
Adial Pharmaceuticals, Inc. Share price
17 May 2023 12:43 GMT
$0.3255
0.0 (0.87 %)
Adial Pharmaceuticals, Inc. Market cap
$9.91 M
WMC RANKING
2024
Adial Pharmaceuticals, Inc. # 392
BiotechnologyLatest Adial Pharmaceuticals, Inc. News
12 Feb 2024
Alcohol Use Disorder Treatment Market Embarks on Futuristic Finances, Targeting US$ 1,300 Million Valuation by 2033
According to a recent FMI analysis, the size of the global alcohol use disorder treatment market is expected to grow at a 6.4% CAGR between 2023 and 2033.
12 Feb 2024
Does Adial Pharmaceuticals Inc (ADIL) Have What it Takes to be in Your Portfolio Monday?
The 37 rating InvestorsObserver gives to Adial Pharmaceuticals Inc (ADIL) stock puts it near the bottom of the.
12 Feb 2024
Alcohol Use Disorder Treatment Market Embarks on Futuristic Finances, Targeting US$ 1,300 Million Valuation by 2033
According to a recent FMI analysis, the size of the global alcohol use disorder treatment market is expected to grow at a 6.4% CAGR between 2023 and 2033.
WMC Market Score
WMC Market to Revenue Score
Adial Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
Adial Pharmaceuticals, Inc. | USD | $0 | $13,468 | $-13,450 | $99M | 392 |
Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ 0.00 | 3 |
ALK-Abello A/S | USD | $3,556,000 | $1,893,000 | $66,000 | $189,400B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Adial Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
Adial Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
Adial Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Adial Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Adial Pharmaceuticals, Inc. WMC Market Score Calculations
Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
Adial Pharmaceuticals, Inc. | 0 | 1.48 | 0.06 | 0 | 0 | 0 | 0.55 |
Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 70 | 0 | 0 | 39.85 |
Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 100 | 0 | 0 | 51.56 |
Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 80 | 0 | 0 | 100 |
ALK-Abello A/S | 38.66 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge